%0 Journal Article
%T Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma
%A Tomislav Tadin
%A Kristian Krpina
%A Sanja £¿tifter
%A Emina Babarovi£¿
%A £¿eljko Fu£¿kar
%A Nives Jonji£¿
%J Diagnostic Pathology
%D 2012
%I BioMed Central
%R 10.1186/1746-1596-7-152
%X In order to analyze the predictive value of cyclooxygenase-2 (COX-2) expression and tumor infiltrating lymphocytes (TILs) in recurrence of this disease tumor specimens from 127 patients with solitary papillary non-muscle invasive bladder cancer (NMIBC), 78 with recurrent disease and 49 without recurrence during follow up of minimum 5 years, were retrieved for tissue microarrays construction and immunohistochemical analysis. COX-2 expression was scored according to Allred¡¯s scoring protocol, while presence of TILs was categorized as absent (no) or present (yes) on whole tissue sections.COX-2 immunoreactivity was presented in 70 (71%), weak in 16% and strong in 55% of cases, while 29 (29%) tumors were negative. TILs were present in 64 (58%) NMIBC, while 44 cases (41%) did not reveal mononuclear infiltration in tumoral stroma. Statistical analysis demonstrated a higher proportion of patients with recurrence in the group with the COX-2 score 0, and lower in the group with score 2 (p=0.0001, p=0.0101, respectively). In addition, a higher proportion of recurrent patients in the group with no TILs, and lower proportion in the group with TILs were found (p=0.009, p=0.009, respectively). Univariate and multivariate analysis revealed overexpression of COX-2 and presence of TILs as negative predictors.Patients with lower COX-2 expression and absence of TILs in NMIBC need to be followed up more vigorously and probably selected for adjuvant therapy.The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1411318819790406 webciteUrinary bladder cancer (UBC), on the average, includes 2% of all the malignant diseases with male-to-female ratio being about 4:1. The incidence of UBC increases with age [1]. The mortality from transitional cell carcinoma (TCC) of the urinary bladder increases significantly with the progression of superficial to invasive disease. Approximately 75-85% of patients present with a non-muscle invasive bladder carc
%K Non-muscle invasive bladder cancer
%K Recurrence
%K Cyclooxygenase-2
%K Tumor infiltrating lymphocytes
%U http://www.diagnosticpathology.org/content/7/1/152